Karel Marcel Van Praet

Karel Marcel Van Praet

Auto-generated profile, based on publicly available information

Karel Marcel Van Praet

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Closed access
PDF file
KPKarel M Van Praet
Karel M Van Praet
CSChristof Stamm
Christof Stamm
SSSimon H Sündermann
Simon H Sündermann
AMAlexander Meyer
Alexander Meyer
AUAxel Unbehaun
Axel Unbehaun
JKJörg Kempfert
Jörg Kempfert
Minimally invasive surgical mitral valve repair (MVRepair) has become routine for the treatment of mitral valve regurgitation, and indications have been expanded to include reoperations. Current European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines for the management of valvular heart disease recommended standards in terms of mitral valve disease differentiation, timing of intervention and surgical techniques to improve patient care. Numerous minimally invasive techniques to lessen the invasiveness have been described, such as the minimal-access J-sternotomy (ministernotomy), the parasternal incision, the port-access technique and the right minithoracotomy. Despite the development of catheter-based techniques, surgical repair remains the gold standard today for nearly all patients with degenerative valvular diseases and the majority of patients with other types of valvular diseases. Techniques include resection of the prolapsed segment, neo-chordae implantation and ring annuloplasty. In this review, the current indications for mitral valve surgery are summarised and state-of-the-art MVRepair techniques are highlighted.

19 May 2021 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
KPKarel M Van Praet
Karel M Van Praet
MKMarkus Kofler
Markus Kofler
TSTimo Z Nazari Shafti
Timo Z Nazari Shafti
AAAlaa Abd El Al
Alaa Abd El Al
AKAntonia van Kampen
Antonia van Kampen
SJStephan Jacobs
Stephan Jacobs
Minimally invasive coronary revascularisation was originally developed in the mid 1990s as minimally invasive direct coronary artery bypass (MIDCAB) grafting is a less invasive approach compared to conventional coronary artery bypass grafting (CABG) to address targets in the left anterior descending coronary artery (LAD). Since then, MIDCAB has evolved with the adoption of a robotic platform and the possibility to perform multivessel bypass procedures. Minimally invasive coronary revascularisation surgery also allows for a combination between the benefits of CABG and percutaneous coronary interventions for non-LAD lesions – a hybrid approach. Hybrid coronary revascularisation results in fewer blood transfusions, shorter hospital stay, decreased ventilation times and patients return to work sooner when compared to conventional CABG. This article reviews the available literature, describes standard approaches and considers topics, such as limited access procedures, indications and patient selection, diagnostics and imaging, techniques, anastomotic devices, hybrid coronary revascularisation and outcome analysis.

1 September 2020 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
KPKarel M. Praet
Karel M. Praet
AKAntonia Kampen
Antonia Kampen
MKMarkus Kofler
Markus Kofler
GRGregor Richter
Gregor Richter
SSSimon H. Sündermann
Simon H. Sündermann
JKJörg Kempfert
Jörg Kempfert
Less-invasive techniques for cardiothoracic surgical procedures are designed to limit surgical trauma, but the technical requirements and preoperative planning are more demanding than those for conventional sternotomy. Patient selection, interdisciplinary collaboration, and surgical skills are key factors for procedural success. Aortic valve replacement is frequently performed through an upper hemisternotomy, but the right anterior minithoracotomy represents an even less traumatic, technical advancement. Preoperative assessment of the ascending aorta in relation to the sternum is mandatory to select patients and the intercostal access site. This description of the surgical technique focuses on the specific procedural details including the obligatory planning with computed tomography and our cannulation strategy. We also sought to define the anatomical ascending aorta-sternal relationship, as it is of utmost importance in preoperative computed tomographic planning.

4 March 2021 in Expert Review of Medical Devices
Verified
Journal Article
Closed access
KPKarel M. Van Praet
Karel M. Van Praet
JKJörg Kempfert
Jörg Kempfert
SJStephan Jacobs
Stephan Jacobs
CSChristof Stamm
Christof Stamm
SASerdar Akansel
Serdar Akansel
VFVolkmar Falk
Volkmar Falk
Introduction. During the past five years the approach to procedural planning, operative techniques and perfusion strategies for minimally invasive mitral valve surgery (MIMVS) has evolved. With the goal to provide a maximum of patient safety the procedure has been modified according to individual patient characteristics and is largely based on preoperative imaging. Areas covered. In this review article we describe the important factors in image based therapy planning and simulation, different access strategies, the operative key-steps, a rationale use of devices, and highlight a few future developments in the field of MIMVS. Published studies were identified through pearl growing, citation chasing, a search of PubMed using the systematic review methods filter, and the authors’ topic knowledge. Expert opinion. With the help of expert teams including surgeons specialized in mitral repair, anesthesiologists and perfusionists a broad spectrum of mitral valve pathologies and related pathologies can be treated with excellent functional outcomes. Avoiding procedure related complications is the key for success for any MIMVS program.

2 September 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
KPKarel M Van Praet
Karel M Van Praet
MKMarkus Kofler
Markus Kofler
SHSolveig Hirsch
Solveig Hirsch
SASerdar Akansel
Serdar Akansel
MHMatthias Hommel
Matthias Hommel
JKJörg Kempfert
Jörg Kempfert
OBJECTIVES: Analyses of fast-track (FT) processes demonstrated that low-risk cardiac surgical patients require minimal intensive care, with a low incidence of mortality or morbidity. We investigated perioperative factors and their association with fast-track failure (FTF) in a retrospective cohort study of patients undergoing minimally invasive mitral valve surgery. METHODS: Patients undergoing minimally invasive surgical mitral valve repair for Carpentier type I or type II mitral regurgitation between 2014 and 2020 were included in the study. The definition of FTF consisted of >10 h mechanical ventilation, >24 h intensive care unit stay, reintubation after extubation and re-admission to the intensive care unit. Multivariable logistic regression analysis enabled the identification of factors associated with FTF. RESULTS: In total, 491 patients were included in the study and were analysed. Two hundred and thirty-seven patients (48.3%) failed the FT protocol. Multivariable logistic regression analysis showed that a New York Heart Association classification ≥III [odds ratio (OR) 2.05; 95% confidence interval (CI) 1.38–3.08; P < 0.001], pre-existing chronic kidney disease (OR 2.03; 95% CI 1.14–3.70; P = 0.018), coronary artery disease (OR 1.90; 95% CI 1.13–3.23; P = 0.016), postoperative bleeding requiring surgical revision (OR 8.36; 95% CI 2.81–36.01; P < 0.001) and procedure time (OR 1.01; 95% CI 1.01–1.01; P < 0.001) were independently associated with FTF. CONCLUSIONS: Factors associated with FTF in patients with Carpentier type I and II pathologies undergoing minimally invasive mitral valve repair are a New York Heart Association classification III–IV at baseline, pre-existing chronic kidney disease and coronary artery disease. Postoperative bleeding requiring rethoracotomy and procedure time were also identified as important factors associated with failed FT.

1 January 2018 in Expert Review of Cardiovascular Therapy
Verified
Journal Article
Closed access
KPKarel M. Van Praet
Karel M. Van Praet
CSChristof Stamm
Christof Stamm
CSChristoph T. Starck
Christoph T. Starck
SSSimon Sündermann
Simon Sündermann
AMAlexander Meyer
Alexander Meyer
JKJörg Kempfert
Jörg Kempfert
Introduction: Tricuspid valve regurgitation (TR) is frequently encountered and is most often functional (FTR) in nature. Surgical tricuspid valve (TV) treatment is well established in specialized centers. While transcatheter therapy for other valve disease is well established, interventional treatment of TV disease is still in its early stages. With the increasing adoption of catheter-based treatments, there is a growing interest in and need for interventional treatments for TR. An extensive literature search was methodologically performed aiming for an integrative review paper. Areas covered: This review will discuss the current surgical treatment modalities and emerging transcatheter interventions in the management of TR. Furthermore, this review will describe the pathophysiology of functional tricuspid regurgitation (FTR), and the new 2017 ESC/EACTS guidelines for the management of TR. Finally, a five-year view into the future will be stated. Expert commentary: At their center, the authors have an aggressive approach for the treatment of FTR owing to its significant impact on perioperative as well as late postoperative morbidity and mortality. The authors perform TV ring annuloplasty when substantial annular dilation (>= 45mm) is observed. In the future, percutaneous TV technologies might become an alternative option to treat TR patients with high surgical risk selectively.